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Abstract
Background: Lamins are major structural proteins of the nucleus and contribute to the organization of various nuclear
functions. Mutations in the human lamin A gene cause a number of highly degenerative diseases, collectively termed as
laminopathies. Cells expressing lamin mutations exhibit abnormal nuclear morphology and altered heterochromatin
organization; however, the mechanisms responsible for these defects are not well understood.
Methodology and Principal Findings: The lamin A rod domain mutants G232E, Q294P and R386K are either diffusely
distributed or form large aggregates in the nucleoplasm, resulting in aberrant nuclear morphology in various cell types. We
examined the effects of these lamin mutants on the distribution of heterochromatin protein 1 (HP1) isoforms. HeLa cells
expressing these mutants showed a heterogeneous pattern of HP1a and b depletion but without altering HP1c levels.
Changes in HP1a and b were not observed in cells expressing wild-type lamin A or mutant R482L, which assembled
normally at the nuclear rim. Treatment with proteasomal inhibitors led to restoration of levels of HP1 isoforms and also
resulted in stable association of lamin mutants with the nuclear periphery, rim localization of the inner nuclear membrane
lamin-binding protein emerin and partial improvement of nuclear morphology. A comparison of the stability of HP1
isoforms indicated that HP1a and b displayed increased turnover and higher basal levels of ubiquitination than HP1c.
Transcript analysis of components of the ubiquitination pathway showed that a specific F-box protein, FBXW10 was induced
several-fold in cells expressing lamin mutants. Importantly, ectopic expression of FBXW10 in HeLa cells led to depletion of
HP1a and b without alteration of HP1c levels.
Conclusions: Mislocalized lamins can induce ubiquitin-mediated proteasomal degradation of certain HP1 isoforms by
activation of FBXW10, a member of the F-box family of proteins that is involved in E3 ubiquitin ligase activity.
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Introduction
Lamins are type V intermediate filament proteins that are the
major structural proteins of the nucleus in metazoan cells. Lamins
form a filamentous meshwork underlying the inner nuclear
membrane that extends into the nucleoplasm. Two types of lamins
are found in most species. The B-type lamins B1 and B2 are
expressed in all somatic cells and are coded by separate genes. The A-
type lamins A and C are encoded by a single lamin A gene through
alternative splicing and their expression is detectable in several
differentiated cell types. Lamins are important for maintenance of
nuclear shape and integrity and are involved in the organization of
nuclear functions such as DNA replication and transcription; the A-
type lamins have also been proposed to play important roles in cell
differentiation and gene regulatory pathways. Mutations in the
human lamin A gene (LMNA) are associated with at least 15 highly
degenerative, inherited diseases collectively termed laminopathies.
The majority of mutations in LMNA are missense mutations, though
small deletions and truncations have also been identified. Most of the
mapped mutations cause Emery-Dreifuss muscular dystrophy (EMD)
and dilated cardiomyopathy while other mutations are associated
with progerias and lipodystrophies such as familial partial lipodys-
trophy (FPLD) [1–6].
A number of studies suggest that lamins are important for
chromatin organization, with findings including in vitro binding to
DNA, immunolocalization of the lamina at the nuclear periphery in
close contact with chromatin, and association of lamins with
chromatin-binding proteins such as barrier-to-autointegration factor
(BAF) and lamina-associated polypeptides (LAPs) like LAP2a [5,7,8].
This is further supported by evidence of abnormalities in hetero-
chromatin organization in cells from laminopathic patients, which are
well documented in cells from patients with Hutchinson-Gilford
progeria syndrome (HGPS), an inherited disease arising from a
splicing defect in pre-lamin A [9–14], and those with mandibuloacral
dysplasia type A (MAD-A) due to a R527H mutation in LMNA [15].
Mature lamin A is normally derived from pre-lamin A by extensive
post-translational modifications, namely farnesylation of cysteine in
the C-terminal–CSIM motif, followed by proteolytic cleavage of the
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last three amino acids, carboxymethylation of the farnesylated
cysteine and proteolytic cleavage of the C-terminal 15 amino acids.
On the other hand, HGPS cells express aberrantly processed lamin
A, termed LAD50 or progerin, in which the farnesylated C-terminus
is retained. Abnormal nuclear morphology, defective nuclear
envelopes and disorganization of heterochromatin are also evident
in laminopathic cells expressing EMD mutations that do not lead to
retention of the farnesylated C-terminus [16,17]. Interestingly,
alterations in nuclear positioning of specific chromosomes have been
observed in laminopathic cells [18]. Ectopic expression of disease-
causing lamin mutants in cultured cells also causes abnormal nuclear
morphology, altered lamin assembly and nuclear envelope defects
[16,19–22]. Like other intermediate filament proteins, lamin A is
comprised of a rigid rod domain flanked by globular N-terminal and
C-terminal domains [23]. As the rod domain of the protein is
involved in coiled-coil interactions between lamin dimers, mutations
in this segment are more likely to affect lamin assembly.
In the present study, we analyzed the levels and stability of the
heterochromatin marker, heterochromatin protein 1 (HP1) in
HeLa cells expressing disease-causing lamin A mutants. As our
data showed a substantial loss of specific isoforms of HP1 in cells
expressing the rod domain mutants G232E, Q294P and R386K
that form intranuclear aggregates, we determined whether this
downregulation was due to proteasomal degradation by using
proteasomal inhibitors, analyzed the distribution of lamin A in
treated cells and studied the turnover rates and ubiquitination
levels of HP1 isoforms. Furthermore, we compared the expression
levels of a number of components of the ubiquitination pathway
and studied the effects of overexpression of one F-box protein,
FBXW10 that was highly induced in mutant-expressing cells. Our
findings indicate that lamin mutants can induce ubiquitin-
dependent proteolysis of specific HP1 isoforms by activation of a
distinct F-box protein that is involved in E3 ubiquitin ligase
activity.
Results
Expression of Lamin A Mutants Causes Depletion of
Hp1a and b
We examined the expression of heterochromatin markers in HeLa
cells expressing GFP fused constructs of wild-type lamin A, the rod
domain EMD mutants G232E, Q294P and R386K or the tail
domain FPLD mutant R482L. Our previous studies with these
constructs showed that wild-type GFP-lamin A and R482L were
localized at the nuclear periphery in a typical rim pattern, whereas
G232E, Q294P and R386K did not assemble at the nuclear
periphery but mislocalized to the nucleoplasm where they formed
varying numbers of aggregates, resulting in disruption of the lamina
and abnormal nuclear morphology [22,24]. Mammalian HP1 exists
in three isoforms, a, b and c. HP1a and b are enriched in
heterochromatic foci, whereas HP1c has been detected in both
euchromatin and heterochromatin [25,26]. HeLa cells expressing
wild-type lamin A or R482L displayed normal patterns of expression
of HP1a, b and c in .90% of cells (Figure 1). However, HP1a was
reduced in cells expressing the highly deleterious mutation R386K
and normal levels were observed only in approximately 40% of cells,
whereas 60% of cells expressing Q294P and 70% of cells expressing
G232E showed normal levels of HP1a (Figure 1A and Table 1,
untreated). Importantly, the majority of cells expressing G232E,
Q294P or R386K showed nearly complete depletion of HP1b
(Figure 1B and Table 1, untreated). On the other hand, the
distribution of HP1c was not significantly affected in cells expressing
lamin mutants (Figure 1C). Similar results were obtained with
NIH3T3 mouse fibroblasts (data not shown). In human cells HP1a
and HP1b proteins are diffusely distributed and visibly enriched in
only a few heterochromatic foci.
As HP1a and b proteins bind to histone H3 trimethylated at
lysine 9 (H3K9me3), which is a molecular mark of constitutive
heterochromatin and is associated with silenced genes [27], we
examined the localization of H3K9me3 in cells expressing GFP-
lamin A constructs (Figure 2A). There were no major changes in
the distribution or levels of H3K9me3 in G232E, Q294P or
R386K-expressing cells, though small changes in distribution
could not be ruled out. Histone H4 trimethylated at lysine 20
(H4K20me3), another marker for pericentric heterochromatin
[28], showed slightly reduced staining in cells expressing these
mutants (Figure 2B), but some variability in H4K20me3 staining
was also observed in untransfected cells.
The above results were substantiated by western blot analysis of
cell lysates from FACS-sorted cells (Figure 3) followed by semi-
quantitative analysis by scanning the blots and calculating the
intensities normalized to tubulin. In comparison with untrans-
fected cells, HP1b levels were decreased substantially in cells
expressing G232E (22%), Q294P (44%) or R386K (26%) but not
in cells expressing wild-type GFP-lamin A or R482L (,90%).
HP1a was significantly reduced in cells expressing R386K (48%)
whereas HP1c was not affected by any of the mutants (90–100%).
The levels of H3K9me3 and H4K20me3 were also not
significantly altered. Analysis of samples with anti-lamin A/C
antibody indicated that the GFP constructs were expressed at
levels comparable to endogenous lamin A under our experimental
conditions of 24 h of transfection. Under these conditions,
abnormal lamina assembly due to overexpression of the wild-type
lamin A construct was observed in less than 10% of cells, as
reported earlier [22]. The above immunofluorescence and western
blot data thus indicate that the expression of lamin mutants
G232E, Q294P or R386K results in the depletion of HP1
isoforms, but this does not cause major alterations in the
organization of heterochromatic foci.
Lamin A Mutants Induce Proteasomal Degradation of
HP1a and b
We next examined the possibility that depletion of HP1a and b
might be due to proteasomal degradation by checking the effects of
proteasomal inhibitors. We observed that addition of MG132 led
to restoration of HP1a and b levels in transfected cells. As shown
in Table 1, the percentage of G232E, Q294P or R386K-
expressing cells that were positive for HP1a or b was substantially
higher after MG132 treatment. Treatment with another protea-
somal inhibitor, lactacystin also restored HP1 expression in the
majority of cells expressing these mutants (Table 1). These data
suggest that lamin A mutants induce proteasomal degradation of
HP1a and HP1b. Interestingly, G232E and, to a lesser extent,
Q294P and R386K were localized at the nuclear periphery after
treatment with proteasomal inhibitors (Table 2). Large nuclear
aggregates were reduced in number though the peripheral
localization of these mutants was discontinuous and comprised
of small aggregates (Figure 4). This was accompanied by partial
improvement in the nuclear morphology of these cells. It was
subsequently confirmed by real-time RT-PCR analysis that the
transcript levels of HP1 isoforms were not altered by expression of
lamin mutants (see Table 3).
Lamin A Mutants Assemble Stably at the Nuclear
Periphery after MG132 Treatment
As we had noted that lamin mutants were localized at the
nuclear periphery after treatment with proteasomal inhibitors, we
Lamins and Ubiquitination
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Figure 1. Localization of HP1a, b and c in HeLa cells expressing lamin mutants. (A–C) HeLa cells transiently transfected with the indicated
GFP-tagged lamin constructs were stained with antibodies to HP1a, b or c respectively and counterstained with DAP1 (insets). Arrows indicate
transfected cells depleted of HP1a or b. Bar, 10 mm.
doi:10.1371/journal.pone.0010620.g001
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sought to determine the stability of this structure. Staining of cells
with an antibody to emerin, a lamin-binding protein localized in
the inner nuclear membrane, indicated a depletion of emerin at
the rim and a dispersed, cytoplasmic staining in untreated cells
expressing G232E, Q294P or R386K, as observed in earlier
studies with these constructs [22] as well as with other lamin A
mutants [16,19,20]. Emerin was correctly localized to the nuclear
rim in cells treated with MG132 or lactacystin (Figure 5),
suggesting improvement in stable associations between the lamina
and emerin. From this data we infer that inhibition of proteasomal
activity allows lamin mutants to assemble into a more stable
structure at the nuclear rim.
Table 1. Effect of proteasomal inhibitors on HP1a and HP1b protein levels.
Construct Untreated Untreated MG132-treated MG132-treated Lactacystin-treated Lactacystin-treated
HP1a HP1b HP1a HP1b HP1a HP1b
WT 98.0360.99 90.0066.60 97.4661.78 96.0360.04 89.87610.74 87.5160.70
G232E 69.36613.95 23.8765.84 82.2867.16 87.3362.83 68.7568.39 65.13610.23
Q294P 61.4265.54 38.04612.32 90.4662.62 83.3160.58 86.23615.89 61.3365.66
R386K 38.2465.75 38.7465.83 87.2660.11 72.8164.51 85.31610.04 61.1969.56
R482L 91.4464.86 94.7263.70 96.7960.96 95.3564.74 86.5468.16 95.3760.89
Values represent percentages of cells (mean 6 SD) showing normal levels of HP1a or HP1b proteins, calculated from three independent experiments in which n= 75
transfected cells were analyzed in each experiment.
doi:10.1371/journal.pone.0010620.t001
Figure 2. Localization of methylated histones in cells expressing lamin mutants. (A,B) HeLa cells were transiently transfected with the
indicated GFP-tagged lamin constructs and stained with antibodies to H3K9me3 or H4K20me3 respectively. Bar, 10 mm.
doi:10.1371/journal.pone.0010620.g002
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To investigate whether factors other than restoration of
emerin might be involved in location of lamin mutants at the
nuclear periphery, the following experiments were carried out.
We firstly analyzed the effects of MG132 on cells expressing
LAD50, as this relocation could be due to MG132-induced
changes in C-terminal farnesylation or processing. A number of
studies have shown that the lobulated nuclear morphology of
cells expressing LAD50 can be improved by drugs that block
farnesylation of the C-terminus [12,13,29–32]. However, the
aberrant nuclear morphology of LAD50-expressing cells was not
altered, suggesting that C-terminal farnesylation was not
affected by MG132 (Figure 6A). Interestingly, there were no
significant changes in the levels of HP1a or b upon LAD50
expression. Secondly, we determined whether MG132 treat-
ment altered the levels of pre-lamin A in cells expressing lamin
A mutants, by staining with an antibody specific to the
unprocessed C-terminus of pre-lamin A. There were no
significant differences in the levels of pre-lamin A staining in
treated and untreated cells expressing G232E, Q294P or
R386K, though these mutants were located at the periphery
after treatment with MG132 as expected (Figure 6B). Trans-
fected cells expressed higher amounts of unprocessed wild-type
and mutant GFP-lamins compared to endogenous pre-lamin A,
which was probably due to saturation of the processing
machinery by these exogenously expressed full-length lamin
constructs, consistent with an earlier report [33]. We confirmed
by western blot analysis that the electrophoretic mobilities of
endogenous lamin A/C or GFP-lamin A in transfected cells
were not altered after MG132 treatment of cells; although levels
of endogenous lamin A/C were not affected, there was an
increase in the amounts of all GFP-lamin constructs after
MG132 treatment, which could be attributed to their reduced
proteolysis (Figure 6C). The above results suggest that inhibition
of the proteasomal system by MG132 does not affect farnesyla-
tion or processing of the C-terminus of lamin A mutant
constructs.
We also assessed the effects of ectopically expressed HP1b on
the nuclear morphology of G232E, Q294P or R386K-expressing
cells. When GFP-HP1b was co-transfected with mRFP-lamin A
constructs into HeLa cells, mutant lamin A aggregates persisted in
the nuclear interior, nuclear morphology remained distorted and
G232E, Q294P or R386K were not localized to the nuclear
periphery (Figure 6D). Occasional GFP-HP1b foci were coloca-
lized with mutant lamin aggregates. These data demonstrate that
restoration of HP1b is not sufficient to relocate mutant lamins to
the nuclear rim.
HP1a and b are Less Stable than HP1c
The specific degradation of HP1a and b but not HP1c by lamin
misexpression prompted us to compare the stability and solubility
properties of the individual isoforms. An initial assessment of their
inherent stability was obtained by analysis of basal turnover rates
using the protein synthesis inhibitor cycloheximide. HeLa cells
were treated with cycloheximide in a time-course experiment and
levels of HP1 isoforms were analyzed by western blotting
(Figure 7A). We observed that both HP1a and b were degraded
more rapidly than HP1c, which was highly stable. Lamins A/C
and tubulin were also very stable during the course of the
experiment while emerin was comparatively less stable. The
positive control, b-catenin was rapidly degraded as expected. Next,
we assessed the ubiquitination levels of the endogenous HP1
isoforms by immunoprecipitation of cell lysates with antibodies to
HP1 proteins followed by western blot analysis of the immuno-
precipitates with antibody to ubiquitin. As shown in Figure 7B,
both HP1a and b immunoprecipitates showed higher levels of
ubiquitination compared to HP1c (which was similar to the
control immunoprecipitate). We then checked the binding of the
individual HP1 isoforms to nucleoskeletal fractions of HeLa cells
prepared by two different procedures. All three isoforms were
completely solubilized by extraction of nuclei under strong
conditions with a combination of detergents to deplete most
soluble proteins, but HP1a and HP1c were bound to the
nucleoskeleton under milder conditions (Figure 7C). Lamins A
and C were retained in the nucleoskeletal fraction in both
procedures. The above findings indicate that, in addition to well-
documented differences in association with heterochromatin and
euchromatin, HP1a and b have a faster turnover rate and higher
levels of basal ubiquitination than HP1c. Furthermore, HP1b is
not as strongly associated with the nucleoskeleton as HP1a and
HP1c.
Figure 3. Expression of chromatin markers in HeLa cells
expressing lamin mutants. Lysates of sorted, transfected cells and
untransfected cells (,50,000 cells per sample) were analyzed by
western blotting with antibodies to the indicated proteins. The results
shown are representative of three independent experiments.
doi:10.1371/journal.pone.0010620.g003
Table 2. Effect of proteasomal inhibitors on localization of
GFP-lamin A constructs.
Construct Untreated MG132-treated
Lactacystin-
treated
WT 96.3561.71 98.0761.65 93.8966.62
G232E 19.6266.09 83.2266.11 73.2069.07
Q294P 9.0962.21 69.7765.16 46.2066.40
R386K 15.4165.11 61.0166.40 39.7668.57
R482L 95.3962.77 97.4161.81 92.6167.18
Values represent percentages of cells (mean 6 SD) showing localization of GFP-
lamin A constructs at the nuclear rim, calculated from four independent
experiments in which n= 75 transfected cells were analyzed in each
experiment.
doi:10.1371/journal.pone.0010620.t002
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Lamin Mutants Activate a Specific F-Box Protein
The induction of proteasomal degradation by lamin mutants
prompted us to check whether specific components of the
ubiquitin-proteasome system were activated by the mutants. This
system is comprised of an E1 ubiquitin activating enzyme, an E2
ubiquitin conjugating enzyme and an E3 ubiquitin ligase.
Substrate specificity is conferred by the large variety of E3
enzymes that can recognize distinct substrates through specific
domains or modules [34]. In order to identify differentially
regulated transcripts in this pathway, RNA was analyzed from
stably transfected HeLa cells harbouring wild-type GFP-lamin A
and representative mutants G232E and R386K. Cells transfected
with the GFP vector alone and untransfected cells were used as
controls. After an initial analysis of transcripts of 85 genes by a
PCR array of different components of the ubiquitination pathway
(SABioscience, data not shown), we chose 20 genes that had shown
at least 1.5-fold changes in levels for detailed study. Transcripts
were quantitated by real-time RT-PCR analysis and the results are
shown in Table 3. A substantial upregulation of 5.6-fold in the
presence of G232E and 2.3-fold in the presence of R386K mutant
was observed with a gene coding for an F-box family protein,
termed FBXW10. As F-box proteins are components of the RING
family of E3s [35], other members of these complexes such as the
cullins, CAND1, RBX1 and SKP1 were also analyzed, but
transcript levels of these genes were not significantly affected by
lamin mutants. We noted that levels of cullin 4, which has been
implicated in heterochromatin formation [36], were not altered.
On the other hand, moderate induction of the HECW2 ligase and
RNF123 RING finger protein was observed with G232E and
R386K-expressing cells respectively (but not both).
As the F-box proteins are important determinants of substrate
specificity in the ubiquitination process, we carried out further
experiments with FBXW10. The gene was cloned by PCR and
expressed as an epitope-tagged protein in HeLa cells. RFP-
FBXW10 was located mostly in the cytoplasm of transfected cells.
Interestingly, expression of FBXW10 resulted in the depletion of
HP1a and b in 80–90% of cells without alteration of HP1c levels
(Figure 8). In the majority of cells (,80%), emerin was dispersed in
the cytoplasm while the remainder showed peripheral localization
of emerin. However, nuclear rim staining of endogenous lamin A
Figure 4. Restoration of HP1b after treatment with proteasomal inhibitors. HeLa cells transiently transfected with lamin constructs were
treated with 6 mM MG132 or 10 mM lactacystin and stained with antibodies to HP1b. Arrows indicate transfected cells showing restoration of HP1b.
Bar, 10 mM.
doi:10.1371/journal.pone.0010620.g004
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was not altered, suggesting that expression of FBXW10 and
depletion of HP1 do not directly cause lamin mislocalization. We
conclude from these experiments that expression of a specific F-
box protein that is induced by lamin mutants results in depletion of
HP1a and b and disruption of emerin localization.
Discussion
In this study, we report that HP1a and b undergo proteasomal
degradation in cells expressing lamin mutants that predominantly
form intranuclear aggregates. Treatment with proteasomal
inhibitors restores HP1a and HP1b, and locates G232E, Q294P
and R386K together with emerin to the nuclear periphery.
Analysis of components of the ubiquitination pathway indicates
that expression of the F-box protein FBXW10 is highly induced in
mutant-expressing cells, and ectopic expression of FBXW10
results in specific depletion of HP1a and b. The implications of
our results are discussed with respect to the effects of lamin
misexpression on chromatin organization, lamina assembly and
protein ubiquitination.
Lamins and Chromatin Organization
At the nuclear periphery, the lamina is closely associated with
inner nuclear membrane proteins such as lamin B receptor and
emerin, and the chromatin-binding protein BAF [7,8]. Lamin B
receptor interacts with B-type lamins and HP1 while emerin binds
to both A-type lamins and BAF. In the nuclear interior, LAP2a
associates with chromatin and intranuclear lamin A [37,38]. Thus
lamins associate with chromatin either directly or indirectly
through bridging proteins. The importance of the lamina network
for proper chromatin organization is supported by the observation
of heterochromatin fragmentation in Lmna2/2 mouse cardiomy-
ocytes [39], and loss of heterochromatin and occurrence of
developmental defects in lamin null mutants in C. elegans [40].
Furthermore, genome-wide mapping studies have revealed
interactions of B-type lamins with the genome [41,42], and a
number of studies suggest that transcriptionally silent chromatin is
preferentially located at the nuclear periphery [43].
Expression of LAD50 or higher levels of pre-lamin A is toxic
to cells due to persistence of farnesylated lamins, and results
in changes in heterochromatin organization accompanied by
alterations in histone methylation and HP1 distribution
[11–15,29,32,44,45]. Our studies have shown that expression of
lamin A rod domain mutants, but not LAD50, results in
proteolytic degradation of HP1a and b without causing major
changes in the levels or distribution of methylated histones
associated with pericentric heterochromatin. The targeting of
HP1 isoforms for proteasomal degradation in these cells thus
provides an additional mechanism through which lamin mutants
can alter chromatin organization that is distinct from the toxicity
of LAD50 or overexpressed pre-lamin A. A recent study has
identified another progeria mutation, E145K that is highly
disruptive of nuclear structure but does not respond to treatment
with a farnesyl transferase inhibitor [46]. It would be interesting to
know whether the extensive defects in chromatin observed in this
system are due to proteasomal degradation of chromatin proteins.
Table 3. Real-time PCR assays with stably transfected cells.
Gene Function GFP Wild-type G232E R386K
CAND1 Cul1 binding protein 1.7460.42 1.7160.34 1.0560.21 1.2360.24
Cullin1 RING ligase core 1.2060.32 1.3260.34 21.2860.21 1.1860.19
Cullin2 RING ligase core 1.2060.10 1.4660.33 1.4760.30 1.5160.31
Cullin4A RING ligase core 1.3760.21 1.5960.25 21.0960.23 1.0860.21
Cullin4B RING ligase core 2.2160.47 1.9060.47 2.1660.31 1.5160.63
Cullin7 RING ligase core 21.2160.21 21.2260.10 21.3260.28 1.4160.26
DZIP 3 DNA damage 1.1260.13 21.3660.26 1.3060.16 1.3260.22
FBX04 Substrate binding 21.6060.30 21.5660.52 1.3460.33 21.2260.16
FBXW10 Substrate binding 1.7160.43 1.6660.70 5.6460.49 2.3560.44
HECW2 HECT ligase 21.4760.31 1.5560.35 2.9360.37 1.8660.60
RBX1 RING sub-unit 21.2460.22 1.1060.38 21.1760.35 1.2560.34
RNF123 RING finger protein 21.3360.12 21.5960.58 21.5960.49 3.7760.69
RNF148 RING finger protein 1.5760.31 1.2960.31 1.4760.29 1.4360.38
SKP1 Adaptor 1.1460.33 1.5060.24 21.0760.23 1.4760.17
UBE2G2 E2 enzyme 21.6460.27 21.8860.56 21.8460.55 21.3960.24
UBE2J1 E2 enzyme 21.2160.13 21.1560.18 1.3260.38 1.1760.19
UBE2L3 E2 enzyme 1.5060.59 1.4660.34 1.5460.25 1.5460.29
UBE2M E2 enzyme 21.2460.37 1.4060.36 21.3860.17 21.2960.26
UBE2S E2 enzyme 2.6260.45 1.6360.49 1.3760.34 1.8660.57
UBE4B Ubiquitination factor 1.5160.31 1.4460.29 1.3760.32 1.5760.29
HP1a Heterochromatin 1.5760.49 1.4360.37 1.5860.30 1.8160.45
HP1b Heterochromatin 21.5060.34 21.7560.56 21.5460.34 21.6760.39
HP1c Heterochromatin 1.5760.44 1.2860.23 1.4660.39 1.4260.35
Values indicate fold-change (up or down regulation) expressed as mean 6 SD calculated from three independent experiments and normalized to untransfected HeLa
cells.
doi:10.1371/journal.pone.0010620.t003
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Stable Assembly of Lamina at Nuclear Periphery
Wild-type lamins form highly stable polymeric species at the
nuclear periphery while several rod domain lamin A mutants form
less stable aggregates in the nucleoplasm [47–50]. We have observed
that lamin A mutants are localized to the nuclear periphery after
treatment with proteasomal inhibitors. The inhibition of proteasomal
activity might induce stable association of lamin mutants at the
nuclear periphery through direct effects on lamin A structure and
assembly and/or indirect effects on the stability of peripheral lamin-
binding proteins, as the rim localization of lamin A is highly sensitive
to C-terminal post-translational modifications as well as to localiza-
tion of inner membrane-associated proteins such as emerin [51,52].
Since the peripheral localization of G232E, Q294P and R386K in
the presence of proteasomal inhibitors was accompanied by
restoration of emerin at the nuclear periphery, our data emphasize
the importance of stable interactions between lamins and inner
membrane proteins for appropriate nuclear rim localization of
lamins. It is not clear at present whether additional factors might be
involved in the stable assembly of lamin mutants at the nuclear
periphery.
HP1 and Chromatin Organization
Mammalian HP1 isoforms are specifically enriched in hetero-
chromatin or euchromatin and their domains of localization in
turn influence their activities [25]. The localization and mode of
action of HP1 depend on the sequence of the DNA, association
with interacting proteins and the cell type involved, in addition to
binding interactions with H3K9me3 [26,53]. Our data with lamin
A/C mutants imply that a normal lamina is also necessary for
stable expression of HP1a and HP1b, as aberrant lamina assembly
reduces levels of these isoforms by induction of their proteasomal
degradation. Although we have not observed significant alterations
in methylated histones or changes in pericentric chromatin
domains in HeLa cells expressing lamin mutants, which is
consistent with previous reports that depletion of HP1a or b
isoforms does not affect maintenance of pericentric chromatin or
levels of H3K9me3 associated with such domains [54,55], the
possibility exists that loss of HP1 may alter chromatin function and
regulation of specific genes, especially in view of the perinatal
lethality of HP1b knock-out mice [56] and a role for HP1b in
initiating a DNA damage response [57].
Figure 5. Restoration of emerin after treatment with proteasomal inhibitors. HeLa cells transfected with lamin constructs were treated with
MG132 or lactacystin and stained with an antibody to emerin. Arrows indicate dispersed emerin staining; arrowheads point to restored emerin
localization. Bar, 10 mM.
doi:10.1371/journal.pone.0010620.g005
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Protein Ubiquitination and Lamina Organization
The cullin-based E3 ubiquitin ligases, also known as RING E3
ubiquitin ligases, perform most of the targeted protein ubiquitina-
tion that occurs in eukaryotic cells [34]. These are modular ligases
and are comprised of a cullin-based core and a substrate specificity
module. The cullin proteins (Cul 1–7) have diverse functions such
as cell cycle regulation, DNA repair and regulation of develop-
mental processes. In the Cul 1 complex, which is the canonical
Figure 6. Effects of MG132 on lamin A processing. (A) Localization of LAD50. HeLa cells transfected with GFP-tagged LAD50 were treated with
MG132 and stained with antibodies to HP1a, b or c. Arrows indicate untreated transfected cells showing retention of HP1a or b. (B) Localization of
pre-lamin A. HeLa cells transfected with lamin constructs were treated with MG132 and stained with an antibody to pre-lamin A. Arrowheads point to
weak staining of untransfected cells. (C) Lamin profile after treatment with MG132. HeLa cells transfected with lamin constructs and untransfected
cells were treated with MG132 and analyzed by western blotting with antibodies to GFP (upper blot) and lamin A/C (lower blot); U, untreated and T,
treated with MG132. (D) Localization of GFP-HP1b. HeLa cells were co-transfected with GFP-HP1b and RFP-tagged lamin constructs. Bar, 10 mm in
panels A and B, 5 mm in panel D.
doi:10.1371/journal.pone.0010620.g006
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RING ligase, a single SKP1 adaptor protein is bound to a member
of the F-box family of substrate binding proteins, of which there
are 68 members in the human genome [34,35]. However, target
substrates have been identified for only a few F-box proteins. We
have observed that a specific F-box protein, FBXW10 is
upregulated on expression of lamin mutants that form abnormal
nuclear aggregates. Overexpression of FBXW10 resulted in
substantial depletion of HP1a and b, but not HP1c. Endogenous
lamin A levels were not altered in the presence of ectopic
FBXW10, but the majority of cells showed cytoplasmic dispersal of
emerin, suggesting that nuclear envelope structure is susceptible to
the increased degradation triggered by FBXW10.
A role for misexpression of lamin A in activating the ubiquitin-
proteasome system is supported by the finding that in fibroblasts
from a human patient with a homozygous LMNA nonsense
mutation (Y259X) which leads to absence of lamin A, the integral
membrane proteins emerin and nesprin-1a are mislocalized to the
ER and subsequently degraded by the proteasomal machinery
[58]. Also, proteasomal degradation of retinoblastoma protein is
increased in mouse cells derived from lamin A knock-out mice
Figure 7. Stability and solubility of HP1 isoforms. (A) Protein turnover in the presence of cycloheximide. HeLa cells were treated with
cycloheximide (CHX) for 0-28 h and levels of indicated proteins were determined by western blot analysis followed by a semi-quantitative analysis by
scanning of blots. Graphical data is representative of two separate experiments. (B) Basal levels of ubiquitination of HP1 isoforms. Individual HP1
isoforms were immunoprecipitated from HeLa cell lysates and analyzed by western blotting with antibodies to ubiquitin as well as to HP1a, b or c.
Vertical arrows point to multi-ubiquitinated forms of HP1a or b; arrowheads, HP1; ns, non-specific bands; asterisk, IgG light/heavy chain; molecular
mass markers: phosphorylase b, 94 kD; albumin, 67 kD; ovalbumin, 45 kD; carbonic anhydrase, 30 kD; trypsin inhibitor, 21 kD. (C) Matrix association
of HP1 isoforms. HeLa cell monolayers were extracted with Triton X-100, Tween-20 and sodium deoxycholate (strong) or with Triton X-100 only (mild)
followed by nuclease digestion and salt extraction. The extracted pellet, E and unextracted cell lysates, U were analyzed by western blotting with
antibodies to HP1 isoforms and lamin A/C.
doi:10.1371/journal.pone.0010620.g007
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[59]. However, these studies have not addressed the mechanism of
proteasomal degradation by lamin misexpression.
In summary, our study shows for the first time that
inappropriate assembly of lamin A/C leads to proteasomal
degradation of specific heterochromatin proteins by activation of
a distinct F-box protein. Thus ubiquitin-mediated proteasomal
degradation of essential nuclear proteins may afford a distinct
mechanism for the deleterious effects of disease-causing lamin
mutants. Future studies should give insights into the precise
mechanism of action of FBXW10, as well as the involvement of
other components of the E3 ubiquitin ligase systems in these
processes.
Materials and Methods
Plasmid Constructs
Wild-type GFP-lamin A and lamin mutant constructs have been
described earlier [22,60]. Lamin inserts from these pEGFP
plasmids were recloned into an mRFP mammalian expression
vector (Clontech) for specific experiments. A GFP-HPIb expres-
sion vector was kindly provided by Peter Hemmerich (Institute of
Molecular Technology, Jena, Germany). For cloning of full length
human FBXW10 (accession no. NM_031456.3), total cDNA was
obtained from HeLa RNA by reverse transcription using
Superscript II reverse transcriptase kit (Invitrogen) as per the
manufacturer’s instructions. The 3-kb FBXW10 gene was initially
amplified by PCR as three separate fragments, using PhusionTM
high fidelity DNA polymerase (Finnzymes) as per the manufac-
turer’s instructions and with the appropriate primers listed below,
followed by cloning into pMOS vector. Then the middle and 39
fragments were reamplified by overlap PCR to give a single
fragment which was ligated to the 59 fragment after appropriate
enzyme digestion and cloned into XhoI, BamHI-digested pEGFP-
C1 mammalian expression vector (Clontech) and recloned into an
mRFP mammalian expression vector (Clontech). The gene
construct was verified by automated DNA sequence analysis.
The PCR primers used were as follows (added restriction sites in
small case):
(i) 59 fragment, forward: 59ccgctcgagcgATGGAAAACCTG-
GAATCAAGGCTC39; reverse: 59CTCTTGGGCTGTGAACCT-
GAAT39; (ii) middle fragment, forward: 59CCTGTGGACTGCA-
TACCAGAACGA39; reverse: 59GCTAGCATGCGGTTTGGTT-
Figure 8. Effects of FBXW10 on HP1 isoforms and nuclear envelope proteins. HeLa cells transfected with RFP-tagged FBXW10 were stained
with antibodies to HP1 isoforms, emerin or lamin A. Arrows indicate transfected cells depleted of HP1a or b; arrowheads point to dispersed emerin
localization. Values represent mean 6 SD, calculated from three independent experiments in which n= 75 transfected cells were analyzed in each
experiment. Bar, 10 mM.
doi:10.1371/journal.pone.0010620.g008
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T39; (iii) 39 fragment, forward: 59CCCCAGCCCATGATTAT-
CC39; reverse: 59cgggatcccgTCCCAAGGCTGGTTTAGAT39.
Cell Culture, DNA Transfection, Drug Treatment and
Nuclear Extractions
HeLa cells were routinely grown in DMEM supplemented with
10% FBS at 37uC in a humidified atmosphere containing 5%
CO2. Plasmid constructs were transiently transfected into HeLa
cells for 24 h using Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s instructions. Stably transfected cells expressing
wild-type, G232E or R386K GFP-lamin constructs were obtained
by blasticidin selection of HeLa cells transfected with pEGFP
lamin plasmids in which the neomycin resistance cassette was
replaced by a blasticidin resistance cassette. A similar strategy was
used for isolating cells stably transfected with pEGFP control
vector. Alternately, cells transiently expressing wild-type or mutant
GFP-lamin A were enriched by sorting for GFP expression on a
Moflo cell sorter at 488 nm excitation wavelength (which enriched
transfected cells to ,99%) for western blot analysis, as the above
strategy was not successful for obtaining cells stably expressing
Q294P. For treatment with proteasomal inhibitors, cells were
incubated with 6 mM MG132 (Calbiochem) or 10 mM lactacystin
(Calbiochem) for 18 h, starting at 6 h after transient transfection of
plasmids. For protein half-life studies, cells were treated with
100 mg/ml cycloheximide for 0–28 h. Nuclear extractions of cell
monolayers were carried out by a mild extraction protocol using
Triton X-100 as described by De Conto et al. [61] or by a stronger
extraction procedure requiring Triton X-100, deoxycholate and
Tween-20 as described by Nickerson et al. [62].
Antibodies, Western Blot Analysis and
Immunoprecipitations
Polyclonal antibodies to lamin A/C or the C-terminus of pre-
lamin A and a mouse mAb to tubulin were obtained from Santa
Cruz Biotechnology. Polyclonal antibodies or mouse mAbs to
HP1a, b and c were obtained from Upstate or Chemicon.
Polyclonal antibodies to H4K20me3 and H3K9me3 were from
Abcam and Upstate respectively. Mouse mAbs to emerin (clone
4G5) and ubiquitin were from Novocastra Laboratories and
Calbiochem respectively. For western blot analysis, samples
(,50,000 cells per sample) were lysed in Laemmli’s sample buffer,
boiled and electrophoresed through SDS-10% polyacrylamide
gels. Gels were electroblotted onto PVDF membrane filters and
blocked overnight in 5% BLOTTO in Tris-buffered saline
containing 0.1% Tween-20. Filters were incubated with primary
antibody for 2 h, followed by peroxidase conjugated-secondary
antibody in Tris-buffered saline containing 0.1% Tween-20 for
1 h. Bound antibody was visualized using a chemiluminescence kit
from Roche Applied Science. For immunoprecipitation assays,
cells were lysed in cold RIPA buffer containing 20 mM Tris.HCl,
pH 7.4, 150 mM NaCl, 1% NP-40, 1 mM PMSF, 20 mM NaF,
1 mM sodium vanadate and protease inhibitors. The precleared
samples were immunoprecipitated with primary antibody followed
by protein A-Sepharose beads and the bound proteins were
analyzed by western blotting.
Immunofluorescence Microscopy
Transfected HeLa cells were washed with PBS and then fixed
with 4% formaldehyde in phosphate-buffered saline (PBS) for
10 min followed by treatment with 0.5% (vol/vol) Triton X-100
for 6 min at room temperature. Cells were then incubated with
0.5% gelatin in PBS for 1 h followed by incubation with primary
antibody for 1 h and then Cy3- or FITC-conjugated secondary
antibody for 1 h at room temperature. Samples were mounted in
Vectashield (Vector Laboratories) containing 1 mg/ml DAPI.
Fluorescence microscopy of fixed cells was performed on an
LSM510 META or LSM510 META/NLO confocal microscope.
DAPI staining was routinely viewed in the transmission mode.
Images were analyzed with LSM 510 META software and
assembled using Adobe Photoshop.
Quantitative RT-PCR Analysis
Total RNA was extracted from stably transfected HeLa cells
and 1 mg of RNA was reverse transcribed using Superscript II
reverse transcriptase kit (Invitrogen) as per the manufacturer’s
instructions. Amplification of PCR products was quantitated
using SyBR green dye (ABI), and fluorescence was monitored on
an ABI prism 7900HT sequence detection system. Melting curve
analysis was done for each amplicon. The 22DDCt method was
used for quantitation with HPRT1 (hypoxanthine phosphoribosyl
transferase 1) as endogenous control. The analysis for each gene
was done in triplicate and three independent biological replicates
were performed. Gene expression in transfected cells was
expressed as fold change in comparison with untransfected HeLa
cells. The gene specific primers used for the analysis are given in
Table S1.
Supporting Information
Table S1 List of primers used for real-time PCR analysis.
Found at: doi:10.1371/journal.pone.0010620.s001 (0.05 MB
DOC)
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